View Older Stories View More Recent Stories

Feb 21, 2020 08:37AM Agile Therapeutics (AGRX) Prices 15M Share Offering at $3/Sh
Feb 21, 2020 08:35AM Agile Therapeutics Announces Pricing of $45 Million Underwritten Public Offering of Common Stock
Feb 21, 2020 08:35AM Agile Therapeutics Announces Pricing of $45 Million Underwritten Public Offering of Common Stock
Feb 20, 2020 04:21PM Agile Therapeutics (AGRX) to Offer Common Stock
Feb 20, 2020 04:14PM Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
Feb 20, 2020 04:14PM Agile Therapeutics Announces Proposed Underwritten Public Offering of Common Stock
Feb 18, 2020 06:40AM Agile Therapeutics (AGRX) Announces FDA Approval of Twirla Transdermal System
Feb 14, 2020 06:46PM FDA Approves Agile Therapeutics, Inc.’s Twirla® (levonorgestrel and ethinyl estradiol) Transdermal System – A New Weekly Contraceptive Patch Delivering a 30 mcg Daily Dose of Estrogen and 120 mcg
Feb 14, 2020 06:46PM FDA Approves Agile Therapeutics, Inc.’s Twirla® (levonorgestrel and ethinyl estradiol) Transdermal System – A New Weekly Contraceptive Patch Delivering a 30 mcg Daily Dose of Estrogen and 120 mcg
May 3, 2019 08:00AM Agile Therapeutics to Present Combined Safety Data from Three Phase 3 Studies at the 2019 ACOG Annual Meeting
May 3, 2019 08:00AM Agile Therapeutics to Present Combined Safety Data from Three Phase 3 Studies at the 2019 ACOG Annual Meeting
Mar 15, 2019 08:00AM Agile Therapeutics to Present In Vivo Adhesion Data from Two Phase 1 Studies at the 2nd Annual Formulation & Drug Delivery USA Congress
Mar 15, 2019 08:00AM Agile Therapeutics to Present In Vivo Adhesion Data from Two Phase 1 Studies at the 2nd Annual Formulation & Drug Delivery USA Congress
Mar 4, 2019 07:32AM Agile Therapeutics (AGRX) Announces $7.8 Million Private Placement of Common Stock
Mar 4, 2019 07:30AM Agile Therapeutics Announces $7.8 Million Private Placement
Mar 4, 2019 07:30AM Agile Therapeutics Announces $7.8 Million Private Placement
Feb 11, 2019 07:37AM Agile Therapeutics (AGRX) Announces Twirla Meets Primary Endpoint in Comparative Wear Study and Demonstrates Non-Inferior Adhesion to Xulane
Feb 11, 2019 07:30AM Agile Therapeutics, Inc. Announces that Twirla® Meets Primary Endpoint in Comparative Wear Study and Demonstrates Non-Inferior Adhesion to Xulane®
Feb 11, 2019 07:30AM Agile Therapeutics, Inc. Announces that Twirla® Meets Primary Endpoint in Comparative Wear Study and Demonstrates Non-Inferior Adhesion to Xulane®
Jan 10, 2019 04:27PM Agile Therapeutics (AGRX) Provides Regulatory Update and Reiterates Cash Guidance
Jan 10, 2019 04:15PM Agile Therapeutics, Inc. Provides Regulatory Update and Reiterates Cash Guidance
Jan 10, 2019 04:15PM Agile Therapeutics, Inc. Provides Regulatory Update and Reiterates Cash Guidance
Dec 13, 2018 04:20PM Agile Therapeutics (AGRX) Meets With FDA on Comparative Wear Study of Twirla and Xulane
Dec 13, 2018 04:15PM Agile Therapeutics, Inc. Meets With FDA on Comparative Wear Study of Twirla® and Xulane®
Dec 13, 2018 04:15PM Agile Therapeutics, Inc. Meets With FDA on Comparative Wear Study of Twirla® and Xulane®
Oct 24, 2018 08:09AM Agile Therapeutics (AGRX) Highlights Additional Analyses of AG200-15 (Twirla) Phase 3 SECURE Study Results
Oct 24, 2018 08:00AM Agile Therapeutics, Inc. Presents Additional Analyses of AG200-15 (Twirla®) Phase 3 SECURE Study Results at the 2018 North American Forum on Family Planning (NAFFP)
Oct 9, 2018 08:03AM Agile Therapeutics (AGRX) Completes Formal Dispute Resolution Process with the FDA
Oct 9, 2018 08:00AM Agile Therapeutics, Inc. Completes Formal Dispute Resolution Process with the FDA
Oct 9, 2018 08:00AM Agile Therapeutics, Inc. Completes Formal Dispute Resolution Process with the FDA
Jul 24, 2018 04:26PM Agile Therapeutics (AGRX) Reports Initial Formal Dispute Resolution Request Denial from FDA for Twirla
Jul 24, 2018 04:10PM FDA’s Office of Drug Evaluation III Denies Agile Therapeutics, Inc.’s Initial Formal Dispute Resolution Request
Jul 24, 2018 04:10PM FDA’s Office of Drug Evaluation III Denies Agile Therapeutics, Inc.’s Initial Formal Dispute Resolution Request
Jun 7, 2018 04:10PM Agile Therapeutics, Inc. Provides Corporate Update and Revised Cash Guidance
Jun 7, 2018 04:10PM Agile Therapeutics, Inc. Provides Corporate Update and Revised Cash Guidance
May 18, 2018 07:35AM Agile Therapeutics (AGRX) Provides Twirla Update; Says FDA Has Significant Concerns Regarding the Adhesion of Twirla
May 18, 2018 07:35AM Agile Therapeutics (AGRX) Announces Regulatory Update on Twirla; FDA Continues to have Significant Concerns
May 18, 2018 07:30AM Agile Therapeutics, Inc. Provides Regulatory Update on Twirla® (AG200-15) for the Prevention of Pregnancy
May 18, 2018 07:30AM Agile Therapeutics, Inc. Provides Regulatory Update on Twirla® (AG200-15) for the Prevention of Pregnancy
Mar 14, 2018 07:45AM Abstract on AG200-15 (Twirla®) Accepted for Presentation at the APhA 2018 Annual Meeting & Exposition
Mar 14, 2018 07:45AM Abstract on AG200-15 (Twirla®) Accepted for Presentation at the APhA 2018 Annual Meeting & Exposition
Dec 22, 2017 07:31AM Agile Therapeutics (AGRX) Receives CRL from FDA for Twirla for Prevention of Pregnancy
Dec 22, 2017 07:30AM Agile Therapeutics, Inc. Receives a Complete Response Letter from the FDA for Twirla® (AG200-15) for the Prevention of Pregnancy
Dec 22, 2017 07:30AM Agile Therapeutics, Inc. Receives a Complete Response Letter from the FDA for Twirla® (AG200-15) for the Prevention of Pregnancy
Oct 31, 2017 07:46AM Agile Therapeutics (AGRX) Announces Additional Phase 3 SECURE Trial Results for Twirla
Oct 31, 2017 07:45AM Agile Therapeutics Presents Additional Phase 3 SECURE Trial Results for Twirla® at the American Society for Reproductive Medicine (ASRM) Scientific Congress & Expo 2017
Oct 2, 2017 07:30AM Agile Therapeutics to Host First Analyst Day on October 10, 2017
Sep 28, 2017 07:47AM Agile Therapeutics (AGRX) to Present Additional Phase 3 Data on AG200-15
Sep 28, 2017 07:45AM Agile Therapeutics to Present Additional Phase 3 Data at the North American Forum on Family Planning Annual Meeting
Sep 14, 2017 07:45AM Agile Therapeutics to Present at the Cantor Fitzgerald Global Healthcare Conference
View More Recent Stories View Older Stories